Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-03-17 | 2017-10-11 | 3133 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2017-03-17 | 2017-09-05 | 3140 |
| RATIO-NYSTATIN | 100000UNIT | OINTMENT | Resolved | 2017-03-17 | 2017-09-05 | 3145 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-17 | 2017-04-25 | 3148 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2017-03-17 | 2018-02-22 | 3151 |
| ACT RANITIDINE | 300MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3320 |
| ACT AMLODIPINE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3348 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2018-06-15 | 3357 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-03-17 | 2018-10-11 | 3362 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3366 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3377 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-07-01 | 3381 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3384 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-04-03 | 2017-05-23 | 5165 |
| RATIO-METFORMIN | 850MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5168 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-04-03 | 2018-03-08 | 5171 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5174 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |